The impact of combined inhaled bronchodilator therapy in the treatment of COPD

S Benayoun, P Ernst, S Suissa - Chest, 2001 - Elsevier
Background: Treatment guidelines recommend concomitantuse of ipratropium bromide and
inhaled β 2-agonists asseverity of COPD progresses. While the use of these two agents in …

Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD

M Friedman, CW Serby, SS Menjoge, JD Wilson… - Chest, 1999 - Elsevier
Study objective To conduct a post hoc pharmacoeconomic evaluation of two double-blind,
randomized, prospective, parallel group studies comparing the long-term efficacy and safety …

Bronchodilators use in patients with COPD

YH Dong, CL Hsu, YY Li, CH Chang… - International Journal of …, 2015 - Taylor & Francis
Background Bronchodilators are commonly used as maintenance and rescue therapy in
patients with COPD. We aimed to examine the prescribing patterns of bronchodilators in …

Combination inhaled bronchodilator therapy in the management of chronic obstructive pulmonary disease

J Nichols - … : The Journal of Human Pharmacology and Drug …, 2007 - Wiley Online Library
The Global Obstructive Lung Disease (GOLD) guidelines suggest the potential use of
combination bronchodilator therapy in patients with stage II or higher chronic obstructive …

Changing practices in COPD: a new pharmacologic treatment algorithm

M Friedman - Chest, 1995 - journal.chestnet.org
Chronic obstructive pulmonary disease (COPD) is a serious public health problem, due
largely to cigarette smoking. COPD is now the fourth-leading cause of death in the United …

Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study

CM Kozma, AL Paris, CA Plauschinat, T Slaton… - BMC Pulmonary …, 2011 - Springer
Background The purpose of this analysis was to compare health care costs and utilization
among COPD patients who had long-acting beta-2 agonist (LABA) OR long-acting …

[HTML][HTML] The role of fixed-dose dual bronchodilator therapy in treating COPD

A Anzueto, M Miravitlles - The American journal of medicine, 2018 - Elsevier
The incidence of chronic obstructive pulmonary disease (COPD) is rising in the United
States, and the disease represents a significant source of morbidity and mortality. Primary …

Analysis of inhaled corticosteroid and oral theophylline use among patients with stable COPD from 1987 to 1995

AE Van Andel, C Reisner, SS Menjoge, TJ Witek - Chest, 1999 - Elsevier
Study objective To document temporal usage trends for commonly used respiratory
medications in patients with COPD. Design We retrospectively evaluated baseline …

Extended therapy with ipratropium is associated with improved lung function in patients with COPD: a retrospective analysis of data from seven clinical trials

SI Rennard, CW Serby, M Ghafouri, PA Johnson… - Chest, 1996 - Elsevier
Objective Bronchodilators are routinely used in the long-term therapy of patients with COPD.
These drugs are generally evaluated for their short-term bronchodilatory effects. Long-term …

Long-acting β2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified?

RC Tennant, EM Erin, PJ Barnes, TT Hansel - Current opinion in …, 2003 - Elsevier
Bronchodilators are the mainstay of therapy for patients with established chronic obstructive
pulmonary disease (COPD) but, at present, the majority of patients use short-acting agents …